ResearcherTongji HospitalNo recent work listed

Aiguo Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8541-1671; OpenAlex author ID A5101739269. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper

Papers 2

XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0046624 ↗
LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells. Co-author PMID 21737619 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiayuh Lin · 2 shared papers, 2011–2012 · strength 0.06
- Paper LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells. PMID 21737619 ↗
- Paper XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancre… DOI 10.1371/journal.pone.0046624 ↗
Yan Liu · 1 shared paper, 2012 · strength 0.03
- Paper XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancre… DOI 10.1371/journal.pone.0046624 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.